ARCHIVES

Cancer Meetings Listed

This article is from The Cancer Letter archive.

Vol. 23 No. 41 | October 24, 1997

Download PDF Visit The Full Archive

Related Articles

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

Also David Schwartz of Duke University to head NIEHS.

October 29, 2004

Axitinib Shows Activity Against Advanced Thyroid Cancer

July 27, 2007

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

October 17, 2014

DeVita Will Ask NTP To Return Some NCI Funs To help Cover Shortfall In Center Core Budget

January 18, 1980

UT Southwestern Simmons Cancer Center received $50 million from Simmons family.

November 4, 2005